New York State Common Retirement Fund Actinium Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,737 shares of ATNM stock, worth $7,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,737
Previous 6,737
-0.0%
Holding current value
$7,545
Previous $50,000
74.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ATNM
# of Institutions
74Shares Held
8.31MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$1.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA686KShares$768,4910.0% of portfolio
-
State Street Corp Boston, MA603KShares$674,9660.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$508,1370.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $28.2M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...